Company Profile
Annexon, Inc. Stock Price, News & Analysis
Company overview
Business overview
Annexon is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Annexon is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Annexon follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Annexon sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Why the stock is moving
ANNX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Annexon has a couple of decisive moments ahead, and they are both the sort of milestones that can move the narrative quickly. ARCHER II in geographic atrophy is headed toward topline data, while tanruprubart has already taken a meaningful step in Europe with the Guillain-Barré filing.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Source: Annexon, Inc.
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.